Aoyama Optical Co., Ltd.

Aoyama Optical Co., Ltd. specializes in spectacle frames, which are used for both corrective and non-corrective eyewear. These devices are intended to support vision correction or provide general eye protection and style.

Aoyama Optical Co., Ltd. is based in the United States. Since it operates within the U.S., its devices are subject to FDA regulations. The company’s products fall under the FDA’s Class I classification, which typically involves less stringent premarket review but still requires compliance with quality system regulations.

Aoyama Optical Co., Ltd.’s devices are listed in the FDA’s 510(k) registry. This pathway is used for Class I devices that are substantially equivalent to legally marketed predicates, ensuring they meet FDA requirements for safety and effectiveness before entering the market.

Aoyama Optical Co., Ltd.’s spectacle frames are classified as Class I devices under the FDA’s regulatory framework. Class I devices are generally considered low-risk and often exempt from premarket notification (510(k)) requirements unless they incorporate new technologies or materials. However, the company’s frames are listed via the 510(k) pathway, indicating they meet FDA standards for equivalence to existing devices.